Breaking News Instant updates and real-time market news.

UFS

Domtar

$34.52 /

+0.53 (+1.56%)

07:42
01/08/21
01/08
07:42
01/08/21
07:42

Domtar to sell personal care business to American Industrial Partners for $920M

Domtar announced that it has entered into a definitive agreement to sell its personal care business to American Industrial Partners, or AIP, for $920M. The sale of Domtar's personal care business represents the culmination of a process announced on August 7, 2020, during which the company undertook a comprehensive strategic review of alternatives for the business. The company said the Kingsport conversion provides the company with a strategic entry point to build an up to 2.5M ton business and become a long-term strategic supplier to the packaging industry. With this sale, the company plans to use proceeds generated to pay down debt: Domtar expects to reduce debt by approximately $600M. Also with the proceeds, the company plans to repurchase shares. Domtar expects to repurchase approximately $300M in shares through an accelerated share repurchase program and open market repurchases. The transaction is subject to receipt of regulatory approvals and other customary closing conditions and is expected to close by the end of Q1.

UFS Domtar
$34.52 /

+0.53 (+1.56%)

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/18/20 CIBC
Domtar upgraded to Neutral from Underperformer at CIBC
11/24/20 BofA
BofA upgrades two, downgrades two in paper & packaging reranking
11/24/20 BofA
Domtar upgraded to Neutral from Underperform at BofA

TODAY'S FREE FLY STORIES

General news
FX Update: The dollar ebbed back » 07:20
06/23/21
06/23
07:20
06/23/21
07:20
$ECON

Economic Data

/

+

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Recommendations
AeroVironment investors focus on upcoming results and potential, says Canaccord » 07:19
06/23/21
06/23
07:19
06/23/21
07:19
AVAV

AeroVironment

$112.10 /

+1.12 (+1.01%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

01/15/21 Stifel
AeroVironment downgraded to Hold from Buy at Stifel
01/14/21 Alembic Global
AeroVironment upgraded to Overweight from Neutral at Alembic Global
01/14/21 Baird
AeroVironment upgraded to Outperform after Arcturus deal at Baird
01/14/21 Baird
AeroVironment upgraded to Outperform from Neutral at Baird
AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

Hot Stocks
Pebblebrook sees positive Q2 adjusted EBITDA , positive adjusted FFO in Q321 » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
PEB

Pebblebrook Hotel

$23.39 /

-0.215 (-0.91%)

Pebblebrook Hotel Trust …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

06/14/21 Evercore ISI
Pebblebrook Hotel upgraded to In Line from Underperform at Evercore ISI
03/12/21 BTIG
Pebblebrook Hotel price target raised to $27 from $23 at BTIG
03/01/21 Compass Point
Compass Point more bullish on hotels, upgrades Pebblebrook to Buy
03/01/21 Compass Point
Pebblebrook Hotel upgraded to Buy from Neutral at Compass Point
PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

Recommendations
Motorsport Games news flow could begin mi-July, says Canaccord » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
MSGM

Motorsport Games

$11.39 /

-0.305 (-2.61%)

Canaccord analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

03/25/21 Canaccord
Motorsport Games outlook in line with expectations, says Canaccord
03/16/21 Canaccord
Motorsport Games acquisition strengthens ties with NASCAR, says Canaccord
02/22/21 Canaccord
Motorsport Games portfolio strengthened with KartKraft buy, says Canaccord
02/08/21 Benchmark
Motorsport Games initiated with a Buy at Benchmark
  • 13
    Jan
MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

Recommendations
Microsoft price target raised to $325 from $310 at Wedbush » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
MSFT

Microsoft

$265.49 /

+2.89 (+1.10%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

06/16/21 William Blair
Microsoft gaming news opportunity not threat to Unity, says William Blair
06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

Downgrade
Suruga Bank downgraded to Underweight from Neutral at JPMorgan » 07:14
06/23/21
06/23
07:14
06/23/21
07:14
SUGBY

Suruga Bank

$36.50 /

+ (+0.00%)

JPMorgan analyst Rie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Select Medical price target raised to $50 from $44 at Benchmark » 07:14
06/23/21
06/23
07:14
06/23/21
07:14
SEM

Select Medical

$41.63 /

-0.37 (-0.88%)

Benchmark analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEM Select Medical
$41.63 /

-0.37 (-0.88%)

SEM Select Medical
$41.63 /

-0.37 (-0.88%)

05/21/21 Deutsche Bank
Select Medical price target raised to $48 from $46 at Deutsche Bank
05/13/21 Benchmark
Select Medical price target raised to $44 from $40 at Benchmark
05/10/21 Deutsche Bank
Select Medical price target raised to $46 from $42 at Deutsche Bank
02/26/21 BofA
Select Medical upgraded to Buy from Underperform at BofA
SEM Select Medical
$41.63 /

-0.37 (-0.88%)

SEM Select Medical
$41.63 /

-0.37 (-0.88%)

Initiation
Vale Indonesia initiated with an Overweight at JPMorgan » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
PTNDY

Vale Indonesia

/

+

JPMorgan analyst Benny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Customers Bancorp price target raised to $51 from $42 at Wedbush » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
CUBI

Customers Bancorp

$39.10 /

-0.595 (-1.50%)

Wedbush analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

05/27/21 B. Riley
Customers Bancorp price target raised to $55 from $50 at B. Riley
04/30/21 Maxim
Customers Bancorp price target raised to $52 from $35 at Maxim
04/30/21 B. Riley
Customers Bancorp price target raised to $50 from $41 at B. Riley
03/31/21 B. Riley Securities
Customers Bancorp price target raised to $41 from $39 at B. Riley
CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

Recommendations
BioXcel Therapeutics price target lowered to $125 from $128 at Truist » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
BTAI

BioXcel Therapeutics

$36.88 /

-1.38 (-3.61%)

Truist analyst Robyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

06/01/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $176 from $170 at H.C. Wainwright
05/11/21 H.C. Wainwright
BioXcel Therapeutics price target lowered to $170 from $175 at H.C. Wainwright
04/09/21 Berenberg
BioXcel Therapeutics initiated with a Buy at Berenberg
04/01/21 Truist
BioXcel Therapeutics price target lowered to $127 from $150 at Truist
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

  • 23
    Jun
  • 29
    Jul
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

Hot Stocks
Xebec Adsorption commissions on-site hydrogen generation system for TAYRAS » 07:12
06/23/21
06/23
07:12
06/23/21
07:12
XEBEF

Xebec Adsorption

$3.30 /

-0.0629 (-1.87%)

Xebec Adsorption announce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

06/15/21 Canaccord
Xebec Adsorption price target raised to C$4.50 from C$4 at Canaccord
05/20/21 BMO Capital
Xebec Adsorption initiated with an Outperform at BMO Capital
05/14/21 Canaccord
Xebec Adsorption price target lowered to C$4 from C$4.50 at Canaccord
05/14/21 Stifel
Xebec Adsorption price target lowered to C$5 from C$5.60 at Stifel
XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

Initiation
Aneka Tambang initiated with an Overweight at JPMorgan » 07:12
06/23/21
06/23
07:12
06/23/21
07:12
PAEKY

Aneka Tambang

$15.08 /

-3.39 (-18.35%)

JPMorgan analyst Benny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
VBI Vaccines,Brii Bio present data on BRII-179 study for hepatitis B » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
VBIV

VBI Vaccines

$3.90 /

+0.09 (+2.36%)

Brii Biosciences and VBI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

02/25/21 Jefferies
VBI Vaccines initiated with a Buy at Jefferies
08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

Hot Stocks
Calibre Mining publishes inaugural 2020 sustainability report » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
CXBMF

Calibre Mining

$1.54 /

-0.0581 (-3.64%)

Calibre Mining announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CXBMF Calibre Mining
$1.54 /

-0.0581 (-3.64%)

CXBMF Calibre Mining
$1.54 /

-0.0581 (-3.64%)

04/06/21 Scotiabank
Calibre Mining price target lowered to C$2.75 from C$3 at Scotiabank
03/29/21 BMO Capital
Calibre Mining upgraded to Outperform from Market Perform at BMO Capital
01/14/21 BMO Capital
Calibre Mining initiated with a Market Perform at BMO Capital
10/13/20 Scotiabank
Calibre Mining price target raised to C$3 from C$2.75 at Scotiabank
Recommendations
Incyte's retifanlimab does not seem likely to be approved, says Benchmark » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
INCY

Incyte

$85.07 /

+0.12 (+0.14%)

After the FDA published…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

Hot Stocks
Gildan Activewear becomes member of U.S. Cotton Trust Protocol » 07:09
06/23/21
06/23
07:09
06/23/21
07:09
GIL

Gildan Activewear

$35.79 /

+1.05 (+3.02%)

The U.S. Cotton Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

04/21/21 TD Securities
Gildan Activewear price target raised to $38 from $36 at TD Securities
04/19/21 National Bank
Gildan Activewear price target raised to C$45 from C$43 at National Bank
04/07/21
Fly Intel: Top five analyst upgrades
04/07/21 UBS
Gildan Activewear upgraded to Buy with $43 target at UBS
GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

Downgrade
Canaccord downgrades Plug Power on valuation, higher costs » 07:08
06/23/21
06/23
07:08
06/23/21
07:08
PLUG

Plug Power

$34.00 /

+4.125 (+13.81%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

06:18 Today Barclays
Plug Power price target raised to $27 from $24 at Barclays
05:35 Today Canaccord
Plug Power downgraded to Hold from Buy at Canaccord
06/22/21 Craig-Hallum
Plug Power Q1 filing, reiterated guidance removes overhang, says Craig-Hallum
06/03/21 Roth Capital
Plug Power guidance should rise on new joint venture, says Roth Capital
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

Hot Stocks
Clovis announces LuMIERE study of FAP-2286 open for enrollment » 07:08
06/23/21
06/23
07:08
06/23/21
07:08
CLVS

Clovis

$5.89 /

-0.07 (-1.17%)

Clovis announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLVS Clovis
$5.89 /

-0.07 (-1.17%)

CLVS Clovis
$5.89 /

-0.07 (-1.17%)

06/07/21 Piper Sandler
Clovis reported 'underwhelming datasets' at ASCO, says Piper Sandler
03/19/21 Goldman Sachs
Goldman says Clovis reaction 'disproportionate' for already disclosed data
02/23/21 H.C. Wainwright
Clovis price target lowered to $13 from $15 at H.C. Wainwright
02/23/21 Piper Sandler
Clovis price target raised to $5.75 from $5.00 at Piper Sandler
CLVS Clovis
$5.89 /

-0.07 (-1.17%)

CLVS Clovis
$5.89 /

-0.07 (-1.17%)

CLVS Clovis
$5.89 /

-0.07 (-1.17%)

Downgrade
SmileDirectClub downgraded to Hold at Loop Capital amid inflationary pressure » 07:08
06/23/21
06/23
07:08
06/23/21
07:08
SDC

SmileDirectClub

$8.99 /

-0.16 (-1.75%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$8.99 /

-0.16 (-1.75%)

SDC SmileDirectClub
$8.99 /

-0.16 (-1.75%)

06:45 Today Loop Capital
SmileDirectClub downgraded to Hold from Buy at Loop Capital
05/11/21
Fly Intel: Top five analyst downgrades
05/11/21 Stephens
SmileDirectClub price target lowered to $17 from $19 at Stephens
05/11/21 JPMorgan
JPMorgan downgrades SmileDirectClub after 'mixed' Q1 execution
SDC SmileDirectClub
$8.99 /

-0.16 (-1.75%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$8.99 /

-0.16 (-1.75%)

SDC SmileDirectClub
$8.99 /

-0.16 (-1.75%)

Hot Stocks
Compass Pathways becomes founding supporter of BNA's inaugural scholars program » 07:07
06/23/21
06/23
07:07
06/23/21
07:07
CMPS

Compass Pathways

$35.09 /

-0.84 (-2.34%)

COMPASS Pathways has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPS Compass Pathways
$35.09 /

-0.84 (-2.34%)

CMPS Compass Pathways
$35.09 /

-0.84 (-2.34%)

05/27/21 BTIG
Compass Pathways initiated with a Buy at BTIG
05/11/21
Fly Intel: Top five analyst initiations
05/11/21 Cantor Fitzgerald
Compass Pathways initiated with an Overweight at Cantor Fitzgerald
04/15/21 Canaccord
Psilodep-RCT results suggest Compass pointing in right direction, says Canaccord
CMPS Compass Pathways
$35.09 /

-0.84 (-2.34%)

  • 30
    Apr
  • 18
    Sep
CMPS Compass Pathways
$35.09 /

-0.84 (-2.34%)

Hot Stocks
Foxconn, Gogoro enter MOU for technology and manufacturing partnership » 07:07
06/23/21
06/23
07:07
06/23/21
07:07
HNHPF

Hon Hai Precision

$7.76 /

-0.08 (-1.02%)

Foxconn and Gogoro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HNHPF Hon Hai Precision
$7.76 /

-0.08 (-1.02%)

HNHPF Hon Hai Precision
$7.76 /

-0.08 (-1.02%)

HNHPF Hon Hai Precision
$7.76 /

-0.08 (-1.02%)

Hot Stocks
Gamida publishes results of trial to evaluate omidubicel for stem cell treatment » 07:06
06/23/21
06/23
07:06
06/23/21
07:06
GMDA

Gamida Cell

$6.05 /

-0.01 (-0.17%)

Gamida Cell announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMDA Gamida Cell
$6.05 /

-0.01 (-0.17%)

GMDA Gamida Cell
$6.05 /

-0.01 (-0.17%)

05/11/21 Oppenheimer
Gamida Cell progressing toward omidubicel BLA, says Oppenheimer
05/11/21 JMP Securities
JMP Securities bullish on Gamida Cell, says regulatory preparedness on track
03/09/21 Piper Sandler
Gamida Cell price target lowered to $23 from $25 at Piper Sandler
02/10/21 H.C. Wainwright
Gamida Cell price target raised to $27 from $15 at H.C. Wainwright
GMDA Gamida Cell
$6.05 /

-0.01 (-0.17%)

GMDA Gamida Cell
$6.05 /

-0.01 (-0.17%)

GMDA Gamida Cell
$6.05 /

-0.01 (-0.17%)

Hot Stocks
Olink announces Olink Explore 3072 platform » 07:05
06/23/21
06/23
07:05
06/23/21
07:05
OLK

Olink

$32.33 /

+1.53 (+4.97%)

Olink Holding announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLK Olink
$32.33 /

+1.53 (+4.97%)

OLK Olink
$32.33 /

+1.53 (+4.97%)

04/19/21 SVB Leerink
SVB Leerink bullish on Olink, initiates with an Outperform
04/19/21 SVB Leerink
Olink initiated with an Outperform at SVB Leerink
04/19/21 BTIG
Olink initiated with a Buy at BTIG
04/19/21 Morgan Stanley
Olink initiated with an Equal Weight at Morgan Stanley
OLK Olink
$32.33 /

+1.53 (+4.97%)

  • 25
    Mar
OLK Olink
$32.33 /

+1.53 (+4.97%)

Earnings
Patterson Companies sees FY22 adjusted EPS $1.90-$2.05, consensus $2.10 » 07:05
06/23/21
06/23
07:05
06/23/21
07:05
PDCO

Patterson Companies

$35.16 /

-0.15 (-0.42%)

Sees FY22 deal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
12/30/20 Piper Sandler
Patterson contract loss unexpected but manageable, says Piper Sandler
PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

Hot Stocks
Versus Systems increases fan engagement at 2021 Bassmaster Classic » 07:05
06/23/21
06/23
07:05
06/23/21
07:05
VS

Versus Systems

$5.06 /

-0.04 (-0.78%)

Versus Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VS Versus Systems
$5.06 /

-0.04 (-0.78%)

VS Versus Systems
$5.06 /

-0.04 (-0.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.